Corrigendum to "Design and development of chromene-3-carboxylate derivatives as antidiabetic agents: Exploring the antidiabetic potential via dual inhibition of angiotensin II type 1 receptor and neprilysin enzyme" [Europ. J. Med. Chem. 293 (2025) 117705]
Eur J Med Chem. 2025 Jun 16:117772.
doi: 10.1016/j.ejmech.2025.117772.
Online ahead of print.
1 Department of Pharmacy, Birla Institute of Technology and Sciences Pilani, Pilani Campus, Vidya Vihar, Pilani, 333031, RJ, India.
2 Department of Chemistry, Chaudhary Ranbir Singh University, Jind, 126102, India.
3 Department of Chemistry, COBS&H, Chaudhary Charan Singh Haryana Agricultural University, Hisar, 125004, India. Electronic address: jayantchem@gmail.com.
4 Department of Pharmacy, Birla Institute of Technology and Sciences Pilani, Pilani Campus, Vidya Vihar, Pilani, 333031, RJ, India. Electronic address: hemantrj@pilani.bits-pilani.ac.in.